Clinical trial
An Observer-blind Study to Assess the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Pregnant Women and Infants Born to Vaccinated Mothers
NCT03191383 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observer-blind Study to Assess the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Pregnant Women and Infants Born to Vaccinated Mothers
- Lead sponsor
- GlaxoSmithKline
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- July 11, 2017
- Completion date
- July 14, 2017
- Enrollment
- 0 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.